ENTL Entellus Medical Inc

The Law Offices of Vincent Wong Notifies Investors of a Complaint on Behalf of Entellus Medical, Inc. Shareholders Concerning the Sale of the Company to Stryker Corporation – ENTL

NEW YORK--(BUSINESS WIRE)--

The Law Offices of Vincent Wong announce the commencement of a class action concerning the sale of Entellus Medical, Inc. (NASDAQ:ENTL) to Stryker Corporation (NYSE:SYK). Under the terms of the deal, Entellus shareholders will receive $24.00 in cash for each share of Entellus stock they own.

The action concerns whether the Entellus Board of Directors breached their fiduciary duties to Entellus stockholders by failing to adequately shop the Company before entering into this transaction and whether Stryker Corporation is underpaying for Entellus shares, thus unlawfully harming MGC stockholders.

If you own common stock in Entellus and wish to obtain additional information, please contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or http://docs.wongesq.com/ENTL-Info-Request-Form-1756.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.

39 East Broadway

Suite 304

New York, NY 10002

Tel. 212.425.1140

Fax. 866.699.3880

E-Mail: [email protected]

EN
17/01/2018

Underlying

ENTLEntellus Medical Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Entellus Medical Inc

 PRESS RELEASE
Free
ENTL Entellus Medica...

Multi-Center Market Research Confirms Nasal Valve Collapse as a Contri...

Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers MENLO PARK, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Entellus Medical Inc., now part of Stryker, today announced the publication of a multi-site market research study evaluating symptom severity for nasal airway obstruction (NAO) patients seen in otolaryngology (ENT) practices, and the prevalence of anatomical causes. Results show that the prevalence of nasal valve collapse (NVC) is comparable to septal deviation and turbinate hypertrophy across all patients evaluated and in t...

June 28, 2018 1 EN
 PRESS RELEASE
Free
ENTL Entellus Medica...

Entellus Medical announces publication of the 1-year results of a rand...

Entellus Medical announces publication of the 1-year results of a randomized controlled trial comparing balloon dilation with medical therapy for treatment of persistent Eustachian tube dysfunction PLYMOUTH, Minn., June 19, 2018 (GLOBE NEWSWIRE) -- Entellus Medical, Inc., now a part of Stryker, today announced Otology and Neurotology published results from a study that compares balloon dilation with ongoing medical therapy for the treatment of persistent Eustachian tube dysfunction (ETD). Over 7.3 million people have symptoms of Eustachian tube dysfunction, including ear pain and pressure...

June 19, 2018 1 EN
Free Trial
ENTL Entellus Medica...

Three Directors sold 3,450,975 shares at 24.000USD.

Three Directors at Entellus Medical Inc sold 3,450,975 shares at 24.000USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

ENTL ENTELLUS MEDICAL INC
03/02/18 March 2, 2018 1 EN
 PRESS RELEASE
Free
ENTL Entellus Medica...

The Law Offices of Vincent Wong Notifies Investors of a Complaint on B...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce the commencement of a class action concerning the sale of Entellus Medical, Inc. (NASDAQ:ENTL) to Stryker Corporation (NYSE:SYK). Under the terms of the deal, Entellus shareholders will receive $24.00 in cash for each share of Entellus stock they own. The action concerns whether the Entellus Board of Directors breached their fiduciary duties to Entellus stockholders by failing to adequately shop the Company before entering into this transaction and whether ...

January 17, 2018 1 EN
 PRESS RELEASE
Free
ENTL Entellus Medica...

The Law Offices of Vincent Wong Notifies Investors of an Investigation...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of Entellus Medical, Inc. (NASDAQ:ENTL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Stryker Corporation (NYSE: SYK). Under the terms of the deal, Entellus shareholders will receive $24.00 in cash for each share of Entellus stock they own. The investigation concerns whether the Entellus Board of Directors breached their fiduciary duties to Entellus stoc...

December 13, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch